Lyra Therapeutics Inc
NASDAQ:LYRA

Watchlist Manager
Lyra Therapeutics Inc Logo
Lyra Therapeutics Inc
NASDAQ:LYRA
Watchlist
Price: 3.41 USD -5.01% Market Closed
Market Cap: 6m USD

Intrinsic Value

The intrinsic value of one LYRA stock under the Base Case scenario is 16.87 USD. Compared to the current market price of 3.41 USD, Lyra Therapeutics Inc is Undervalued by 80%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LYRA Intrinsic Value
16.87 USD
Undervaluation 80%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Lyra Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about LYRA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is LYRA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Lyra Therapeutics Inc.

Explain Valuation
Compare LYRA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about LYRA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Lyra Therapeutics Inc

Current Assets 23m
Cash & Short-Term Investments 22.1m
Other Current Assets 964k
Non-Current Assets 20.7m
PP&E 18.7m
Other Non-Current Assets 2m
Current Liabilities 9.5m
Accounts Payable 627k
Accrued Liabilities 5.8m
Other Current Liabilities 3.1m
Non-Current Liabilities 38.6m
Other Non-Current Liabilities 38.6m
Efficiency

Free Cash Flow Analysis
Lyra Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Lyra Therapeutics Inc

Revenue
600k USD
Operating Expenses
-33m USD
Operating Income
-32.4m USD
Other Expenses
-539k USD
Net Income
-32.9m USD
Fundamental Scores

LYRA Profitability Score
Profitability Due Diligence

Lyra Therapeutics Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

17/100
Profitability
Score

Lyra Therapeutics Inc's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

LYRA Solvency Score
Solvency Due Diligence

Lyra Therapeutics Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
50/100
Solvency
Score

Lyra Therapeutics Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LYRA Price Targets Summary
Lyra Therapeutics Inc

Wall Street analysts forecast LYRA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LYRA is 23.46 USD with a low forecast of 16.16 USD and a high forecast of 31.5 USD.

Lowest
Price Target
16.16 USD
374% Upside
Average
Price Target
23.46 USD
588% Upside
Highest
Price Target
31.5 USD
824% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Lyra Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for LYRA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

LYRA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one LYRA stock?

The intrinsic value of one LYRA stock under the Base Case scenario is 16.87 USD.

Is LYRA stock undervalued or overvalued?

Compared to the current market price of 3.41 USD, Lyra Therapeutics Inc is Undervalued by 80%.

Back to Top